AGC plots around 100 layoffs amid tough business environment
10 May 2024 //
FIERCE PHARMA
AGC Biologics, Gore Partner on Purification & Mfg. Services for Antibodies
13 Dec 2022 //
CONTRACTPHARMA
AGC Biologics Honored for Innovations in Cell Line Development
13 Oct 2022 //
PRESS RELEASE
AGC Biologics and Evax Partner to Advance Equine Allergy Vaccine Candidate
09 Sep 2022 //
GLOBENEWSWIRE
AGC and RoosterBio partner for cell and exosome therapy manufacturing
17 Aug 2022 //
PHARMACEUTICAL-TECHNOLOGY
AGC Biologics Supports Altheia Science’s Gene Therapy Programs
28 Jul 2022 //
CONTRACTPHARMA
AGC Biologics Named Manufacturing Company of the Year by American
29 Jun 2022 //
PRESS RELEASE
AGC Biologics Expands Cell and Gene Therapy CDMO Capacity at its U.S. site
18 May 2022 //
AGC
AGC Biologics Provides Aid to Ukraine
11 May 2022 //
PRESS RELEASE
AGC to Expand Synthetic Pharmaceutical Production Base in Spain
07 Apr 2022 //
PRNEWSWIRE
AGC to use recently-expanded Germany site for peanut allergy drug trials
01 Apr 2022 //
ENDPTS
Allergy Selects AGC Biologics to Manufacture Peanut Allergy Vaccine Candidate
31 Mar 2022 //
PRESS RELEASE
AGC Biologics Supports BioNTech Omicron-based Vaccine Candidate with pDNA
08 Feb 2022 //
PRESS RELEASE
AGC Biologics Names Regina Choi-Rivera General Manager of Boulder Facility
18 Jan 2022 //
PRESS RELEASE
AGC Biologics Appoints Jean-Baptiste Agnus as CBO
04 Nov 2021 //
CONTRACTPHARMA
AGC unveils German expansion plans
16 Sep 2021 //
ENDPTS
AGC Biologics expands pDNA and mRNA manufacturing capacity
13 Sep 2021 //
BIOSPECTRUM ASIA
AGC Biologics Breaks Ground on New Facility
23 Aug 2021 //
CONTRACT PHARMA
Often-passed plant in Colorado has a new owner, who`s already operating nearby
07 Jul 2021 //
ENDPTS
AGC is picking up a second commercial plant in CO
03 Jul 2021 //
FIERCEPHARMA
AGC Biologics to Acquire Novartis Facility in Longmont, CO
02 Jul 2021 //
CONTRACTPHARMA
AGC is picking up a second commercial plant in CO
02 Jul 2021 //
FIERCEPHARMA
Chemomab and AGC Biologics Partner to Manufacture CM-101 for Phase II/III
24 Jun 2021 //
CONTRACTPHARMA
AGC Biologics Inks Supply Deal for COVID-19 Vaccine
10 Jun 2021 //
CONTRACT PHARMA
AGC adds major Covid-19 vaccine maker to the client list with BioNTech pact
10 Jun 2021 //
ENDPTS
AGC Biologics and Oculis Enter Manufacturing Deal
07 May 2021 //
CONTRACTPHARMA
Oculis Selects AGC Biologics’ Heidelberg Facility to Manufacture OCS-02
06 May 2021 //
GLOBENEWSWIRE
AGC Biologics Expands Partnership with Rocket Pharmaceuticals
21 Apr 2021 //
CONTRACTPHARMA
AGC Biologics Confirms Cell and Gene Therapy Commercial Expertise as Mfg
04 Jan 2021 //
GONZAGABULLETIN
AGC Biologics Manufactures Orchard Therapeutics` Libmeldy
04 Jan 2021 //
CONTRACTPHARMA
Pierre Fabre Selects AGC Biologics as CDMO the orphan drug ER-004
22 Dec 2020 //
PRNEWSWIRE
AGC Biologics and Horizon Therapeutics plc expand partnership
30 Oct 2020 //
MEDICIRCLE
AGC Biologics and Horizon Therapeutics plc Expand Partnership
29 Oct 2020 //
PRNEWSWIRE
MolMed S.p.A Becomes AGC Biologics S.p.A
28 Oct 2020 //
CONTRACT PHARMA
AGC Biologics Completes PPQ Manufacturing Campaign with Provention Bio
25 Aug 2020 //
PRNEWSWIRE
Japan`s AGC to expand vaccine agent production for Novavax
17 Aug 2020 //
NIKKEI
AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals
12 Aug 2020 //
PRNEWSWIRE
AGC Biologics Expands Partnership with Novavax
10 Aug 2020 //
PRNEWSWIRE
AGC to Complete the Acquisition of MolMed on July 31, 2020
28 Jul 2020 //
PRESS RELEASE
AGC to Complete the Acquisition of MolMed on July 31, 2020
28 Jul 2020 //
PRNEWSWIRE
AGC Biologics Collabo with Molecular Partners to Develop Anti-COVID-19 DARPin®
09 Jul 2020 //
PRNEWSWIRE
AGC Biologics Expands Development Capacities for pDNA Services
06 Jul 2020 //
CONTRACTPHARMA
IPP Announces AGC Biologics Acquisition of AstraZeneca Boulder, CO Plant
04 Jun 2020 //
PRNEWSWIRE
Novavax Selects AGC Biologics to Matrix-M™ Adjuvant for Novel COVID-19 Vaccine
02 Jun 2020 //
PRNEWSWIRE
AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings
01 Jun 2020 //
PRNEWSWIRE
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate
21 May 2020 //
PR NEWSWIRE
AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer
05 May 2020 //
PR NEWSWIRE
Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114
04 Feb 2020 //
YAHOO
Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114
04 Feb 2020 //
PR NEWSWIRE
AGC Biologics expands plasmid DNA capacity
18 Dec 2019 //
FIERCEPHARMA
AGC Biologics Expands Plasmid DNA Offering
17 Dec 2019 //
CONTRACT PHARMA
AGC Biologics Bolsters Denmark Operations
05 Oct 2019 //
CONTRACT PHARMA
AGC Biologics appoints new General Manager for Japan
27 Sep 2019 //
BIOSPECTRUMASIA

Market Place
Sourcing Support